midkine antibodies effective in cancer, page-56

Osi

"Regardless, the MK antibody technology will IMHO see Cellmid rubbing shoulders with some big league players".

IMO, the "POSITIVE DATA IN MIDKINE ANTIBODY STUDY IN KIDNEY DISEASE" https://research.iress.com.au/ids/old/20130123/01375522.pdf?uid=6F9B050D7CAFCAFA842741662E511E58D64400001E9B6D550E4AE440A97B0200AD

is so significant it could potentially lead to collaboration with the Chinese Government and/or investment community. Recent reports suggest that China now leads the world in diabetes with a staggering "estimated 114 million people, or 11.6 percent of the population. Drug companies are making billions.

http://www.medscape.com/viewarticle/810357


http://gbtimes.com/health/china-now-leads-world-diabetes-new-study

http://www.trefis.com/stock/jnj/articles/204747/chinas-diabetes-market-could-become-a-big-focus-for-pharma-companies/2013-09-09